Completed PHASE2 INTERVENTIONAL 1-arm NCT04259658

Histopathologic Effect of Calcium Electroporation on Cancer in the Skin (CAEP-B)

Phase II Investigation of the Histopathologic Effect of Calcium Electroporation on Cancer in the Skin (CAEP-B)

Sponsor: Zealand University Hospital

Conditions Cancer

Updated 9 times since 2020 Last updated: Oct 2, 2023 Started: Apr 20, 2020 Primary completion: Oct 19, 2022 Completion: Jul 27, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Cancer and is currently completed. Zealand University Hospital leads this study, which shows 9 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Nov 2023 — Jul 2024 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Jan 2023 — Nov 2023 [monthly]

Recruiting PHASE2
Apr 2022 — Jan 2023 [monthly]

Recruiting PHASE2

▶ Show 4 earlier versions

Sep 2021 — Apr 2022 [monthly]

Recruiting PHASE2
Jan 2021 — Sep 2021 [monthly]

Recruiting PHASE2
Jul 2020 — Jan 2021 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Mar 2020 — Jul 2020 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zealand University Hospital

Data source: Zealand University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Næstved, Denmark